Latest

public health

Featured Neuroscience Open Neuroscience Articles

·April 6, 2020·4 min read

COVID-19: Self-isolation would dramatically reduce ICU bed demand

Researchers warn that if the US is to avoid the impact on hospitals Italy faces as a result of the coronavirus outbreak, people who are even mildly symptomatic must self isolate to minimize disease transmission.

Featured Neuroscience Neuroscience Videos

·April 5, 2020·5 min read

What the coronavirus does to your body that makes it so deadly

Researchers explore why COVID-19 is more deadly compared to the flu and other viruses.

Featured Neurology Neuroscience Open Neuroscience Articles

·April 5, 2020·2 min read

COVID-19 linked to rare form of encephalitis

A patient who tested positive for COVID-19 developed acute necrotizing encephalitis (ANE) as a result of the coronavirus infection. An MRI scan revealed the patient had lesions in the thalamus and temporal lobes, areas of the brain implicated in consciousness, sensation, and memory function. Researchers advise doctors to look out for COVID-19 patients who present with altered levels of consciousness, as this may be symptomatic of ANE.

Featured Neuroscience Open Neuroscience Articles

·April 4, 2020·4 min read

Study identifies characteristics of patients with fatal COVID-19

Based on data from COVID-19 patients from Wuhan, China, that died as a result of the infection, researchers have identified many symptom commonalities the patients shared.

Featured Neuroscience

·April 4, 2020·4 min read

Clues to COVID-19 coronavirus’s vulnerability emerge from an antibody against SARS

Structural mapping of both SARS and SARS-CoV-2, the virus that causes COVID-19, reveals an almost identical site on both coronaviruses to which the CR3022 antibody binds. This suggests a functionally important and vulnerable site for this family of coronaviruses.

Featured Neuroscience

·April 3, 2020·3 min read

Removing the novel coronavirus from the water cycle

SARS-CoV-2, the virus responsible for COVID-19, can linger for days in sewage and water systems and remain infectious. Researchers call for new studies to determine if current water treatment methods are efficient and effective at killing SARS-CoV-2.

Featured Neuroscience Open Neuroscience Articles

·April 3, 2020·4 min read

Wearing surgical masks in public could help slow COVID-19 pandemic’s advance

Wearing face masks significantly reduced the amounts of airborne virus particles expelled from infected patients. Findings suggest surgical-style face masks could slow the transmission of coronavirus and influenza viruses.

Featured Neuroscience Open Neuroscience Articles

·April 1, 2020·6 min read

Historical coronaviruses show evidence of seasonality & immunity

Historical data from Flu Watch about other coronaviruses reveals they appear to have a seasonal pattern, with peaks occurring during winter. Only small amounts of other coronavirus infections were transmitted during the summer. The findings support the hypothesis that COVID-19 may have lower levels of transmission during the summer, but this may reverse during the winter months if there is still a large, susceptible population.

Featured Neuroscience

·April 1, 2020·4 min read

Aggressive lockdowns need to last more than six weeks to contain COVID-19

Preliminary results from a new model suggest the COVID-19 lockdown should last for more than six weeks. The advice is based on data which shows it takes countries almost three weeks to see a growth rate staying below 10% and doubling time over seven days. It takes a month to keep the growth rate under control and at 1%, and 45 days to achieve containment.

Featured Neuroscience

·April 1, 2020·3 min read

How the novel coronavirus binds to human cells

Compared to the virus that caused the SARS epidemic in the early 2000s, SARS-CoV-2, the virus responsible for COVID-19, has evolved new strategies to bind to cell receptors, resulting in tighter binding. A new study identifies key mutations that potentially enabled the animal-to-human transmission of SARS-CoV-2. The study mapped out important binding sites on SARS-CoV-2 for antibody drugs to act on. If new drugs can bind to the sites on SARS-CoV-2, they will block the virus out of cells.